Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported Q3 Revenue for the quarter came in at $34 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Lyell Immunopharma, Inc. (LYEL) click here.